Anlit's participation at CPhI is part of the company’s strategy to expand its presence in Spain and Latin American countries.
The company has already scheduled several meetings with leading retailers, marketers, pharmaceutical and dietary supplement producers at CPhI.
“CPhI is a great opportunity for Anlit to further expand our presence in Spanish-speaking countries,” said Shai Karlinski, VP marketing at Anlit. "Our products have already enjoyed growing popularity in Eastern Europe and Scandinavia, and there is growing interest in Europe and Latin America.”
Anlit's new product is based on the combination of innovative and patented BLIS K12, the world’s first probiotic for sore throats and ear infections, and xylitol, a natural sweetener that has a unique effect on oral bacteria.
Anlit's oral health supplement supports the oral health system by providing an innovative, natural and active defense against bacterial imbalance in the mouth, fighting antagonistic bacteria that cause sore throats, ear infections, colds and bad breath. The product can be used either in a private label format or directly in drugstores and retail stores under the Anlit brand name.
